SPIRIVA RESPIMAT Is the Only Approved LAMA for Asthma With a Demonstrated Safety Profile1
Multiple clinical trials, with almost 4,500 asthma patients, confirmed the demonstrated safety profile of SPIRIVA RESPIMAT.1
|SPIRIVA RESPIMAT, 2.5 mcg
(two 1.25-mcg puffs) (n=787)
|Pharyngitis||125 (15.9)||91 (12.4)|
|Headache||30 (3.8)||20 (2.7)|
|Bronchitis||26 (3.3)||10 (1.4)|
|Sinusitis||21 (2.7)||10 (1.4)|
*Adverse reactions include a grouping of similar terms.
The adverse reaction profile for pediatric patients (aged 6 to 11 years) and adolescent patients (aged 12 to 17 years) was comparable to that observed in adult patients.1
Add SPIRIVA RESPIMAT for a broad age range of patients1
SPIRIVA RESPIMAT has a demonstrated safety profile for patients as young as 6 years of age1
Drug interactions with concomitant respiratory medications
SPIRIVA RESPIMAT has been used concomitantly with short-acting and long-acting sympathomimetic (beta-agonists) bronchodilators, methylxanthines, oral and inhaled steroids, antihistamines, mucolytics, leukotriene modifiers, cromones, and anti-IgE treatment without increases in adverse reactions.
Drug interactions with other anticholinergics
There is potential for an additive interaction with concomitantly used anticholinergic medications. Therefore, avoid coadministration of SPIRIVA RESPIMAT with other anticholinergic-containing drugs as this may lead to an increase in anticholinergic adverse effects.1
Eligible patients with asthma
may pay as little as $0*
*Eligible commercially insured patients or patient guardians who are 18 years or older may pay as little as $0/month with a maximum savings up to $100/monthly prescription. Card valid for 12 fills per year with benefits not to exceed program expiration on 12/31/2019. If you live in Massachusetts, card expires on the earlier of December 31, 2019, or date AB rated generic equivalent is available. Other state restrictions may apply. One card per patient, not transferable, and cannot be combined with any other offer. Card not accepted in Veteran’s Affairs pharmacies. Program not health insurance. You must present this card to the pharmacist with your Spiriva Respimat prescription to participate. Only valid for commercially insured patients in the 50 United States, territories, DC, and Puerto Rico. Offer not valid for patients without commercial coverage or patients whose prescriptions for Spiriva Respimat are eligible to be reimbursed, in whole or in part, by any governmental program such as Medicaid, Medicare or any state patient or pharmaceutical assistance program and where prohibited by law. Offer may change at any time, without notice.